Qube Research & Technologies (QRT)’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.7M Buy
209,268
+96,476
+86% +$1.79M 0.01% 1687
2025
Q4
$2.01M Buy
+112,792
New +$1.42M ﹤0.01% 2266
2024
Q2
Sell
-4,336
Closed -$66.6K 4863
2024
Q1
$66.6K Buy
+4,336
New +$67.9K ﹤0.01% 3430

Other funds holding ANRO

Qube Research & Technologies (QRT)'s ANRO Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Alto Neuroscience (ANRO) stake by 86% in Q1 2026, buying an estimated $1.79M and bringing the position to 209,268 shares worth $4.7M. The position accounts for 0.01% of the portfolio, ranked #1687.

Qube Research & Technologies (QRT) first reported a position in ANRO in Q1 2024 and has held it in 3 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Qube Research & Technologies (QRT) held 209,268 shares of Alto Neuroscience worth $4.7M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 96,476 Alto Neuroscience shares in Q1 2026, an estimated $1.79M.
  • Alto Neuroscience made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #1687 holding.
  • Qube Research & Technologies (QRT) first reported a position in Alto Neuroscience in Q1 2024 and has held it in 3 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.